Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 67 Next >>

Filter Applied: serologic testing (Click to remove)

Systemic Sclerosis Sine Scleroderma:An Unusual Presentation in Scleroderma Renal Crisis
J Rheumatol 22:557-560, Molina,J.F.,et al, 1995

Unusual Manifestations of Nervous System Borrelia Burgdorferi Infection
Arch Neurol 44:781-783, Midgard,R.&Hofstad,H., 1987

Acquired Toxoplasmosis
Arch Neurol 32:335, Townsend,J.,et al, 1975

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
NEJM 366:1870-1880,1938, Bloomgren, G.,et al, 2012

CSF Complements Serum for Evaluating Paraneoplastic Antibodies and NMO-IgG
Neurol 76:1108-1110, McKeon,A.,et al, 2011

Natalizumab and Progressive Multifocal Leukoencephalopathy: What are the Causal Factors and Can It be Avoided?
Arch Neurol 67:923-930, Warnke,C., et al, 2010

Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies?
Ann Neurol 68:271-274, Tyler,K., 2010

Lyme Disease
NEJM 321:586-596, Steere,A.C., 1989

Serologic Studies in the Diagnosis & Management of Meningitis Due to Sporothrix Schenckii
NEJM 317:935-940, 957-9591987., Scott,E.N.,et al, 1987

Antibody Titers to Coxsackieviruses in Amyotrophic Lateral Sclerosis
NEJM 295:107, Cremer,N.E.,et al, 1976

Progressive Rubella Panencephalitis
NEJM 292:990-993,1023, Townsend,J.,et al, 1975

Chronic Progressive Panencephalitis due to Rubella Virus Simulating Subacute Sclerosing Panencephalitis
NEJM 292:994-998,1023, Weil, M.L.,et al, 1975

Cancer-Related Cognitive Impairment in Patients with Lung Cancer
Neurol 104::e213651, Simo,M.,et al, 2025

Expanding Clinical Spectrum an Anti-GQ1b Antibody Syndrome, A Review
JAMA Neurol 81:762-770, Lee,S-U.,et al, 2024

Clinical Reasoning: A 39-Year-Old Returning traveler with Acute Encephalopathy and Strokes
Neurol 104:e210177, Buback,ClT.,et al, 2024

Clinicopathologic Conference, Cryptococcal Meningoencephalitis
NEJM 391:2361-2369, Case 40-2024, 2024

Neurobrucellosis:The Great Mimicker
Rev Soc Bras Med Trop 55:e0567-e2012, Soares,C.N.,et al, 2022

Neurobrucellosis Brief Review
Neurologist 26:248-252, Bouferraa,Y.,et al, 2021

Clinicopathologic Conference, Powassan Virus Encephalitis
NEJM 380:380-387, Case 3-2019, 2019

Clinicopathologic Conference, Lymphocytic Choriomeningitis Virus Infection
NEJM 381:2553-2560, Case Record 40-2019, 2019

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
JAMA Neurol 73:1297-1307, Fang, B.,et al, 2016

International Consensus Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders
Neurol 85:177-189, Wingerchuk, D.M.,et al, 2015

Extraintestinal Manifestations of Coeliac Disease
Nat Rev Gastroenterol Hepatol 12:561-571, Leffler, D.A.,et al, 2015

Correlation of Clinicoserologic and Pathologic Classifications of Inflammatory Myopathies
Medicine 92:15-24, Fernandez, C.,et al, 2013

Autoimmune Chorea in Adults
Neurol 80:1133-1144, OToole, O.,et al, 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200,2176, Maringer, R.,et al, 2013

Aquaporin-4 Antibody-Positive Cases Beyond Current Diagnosis Criteria for NMO Spectrum Disorders
Neurol 80:2210-2216, Sato, D.,et al, 2013

The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
Medicine 92:223-243, Rider, L.,et al, 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200, 2176, Marignier, R.,et al, 2013

West Nile Virus: Review of the Literature
JAMA 310:308-315,267, Petersen, L.R.,et al, 2013

Mycoplasma Pneumoniae Infection: Neurologic Complications
www.MedLink.com, Oct, Greenlee, J.E., 2013

Serologic Diagnosis of NMO
Neurol 78:665-671, Waters,P.J.,et al, 2012

Clinicopathologic Conference, Rocky Mountain Spotted Fever
NEJM 366:1434-1443, Case 11-2011, 2012

Current Concept of Neuromyelitis Optica (NMO) and NMO Spectrum Disorders
JNNP doi:10.1136/JNNP-2012-302310, Jacob, A.,et al, 2012

Ganglionic Acetylcholine Receptor Autoantibody: Oncological, Neurological, and Serological Accompaniments
Arch Neurol 66:735-741, McKeon,A.,et al, 2009

Pathologic and Immunologic Profiles of a Limited Form of Neuromyelitis Optica with Myelitis
Neurol 73:1628-1637, Yanagawa,K.,et al, 2009

Tick-Borne Encephalitis
Lancet 371:1861-1871, Lindquist,L. &Vapalahti,O., 2008

Liver Involvement in Celiac Disease
Minerva Med 99:595-604, Rubio-Tapia,A. & Murray,J.A., 2008

Diagnosis and Treatment of Neuromyelitis Optica
The Neurologist 13:2-11, Wingerchuk,D.M., 2007

Neuromyelitis Optica IgG Status in Acute Partial Transverse Myelitis
Arch Neurol 63:1398-1400, Scott,T.F.,et al, 2006

Clinicopath Conf, Human Granulocytic Ehrlichiosis
NEJM 352:1358-1364, Case 10-2005, 2005

Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis
JAMA 293:2496-2500, Levin,L.I.,et al, 2005

Epstein-Barr Virus in Pediatric Multiple Sclerosis
JAMA 291:1875-1879, Alotaibi,S.,et al, 2004

West Nile Virus Infection in the United States
Arch Neurol 61:1190-1195, Tyler,K.L., 2004

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003

West Nile Virus: A Primer for the Clinician
Ann Int Med 137:173-179, Petersen,L.R. &Marfin,A.A., 2002

Subacute Sclerosing Panencephalitis
Postgrad Med J 78:63-70, Garg, R.K.,et al, 2002

Response to Cancer Therapy in a Patient with a Paraneoplastic Choreiform Disorder
Neurol 57:719-722, Croteau,D.,et al, 2001

Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis
JAMA 286:3083-3088,3127, Ascherio,A.,et al, 2001



Showing articles 0 to 50 of 67 Next >>